330 Million Reasons to Buy Moderna Stock Right Now
You don't have to try very hard to find reasons to avoid shares of Moderna (NASDAQ: MRNA). Sure, the company reported great efficacy results for its COVID-19 vaccine candidate last week, but its market cap of close to $40 billion already factors in a lot of growth.
With the biotech stock more than quintupling in value so far this year, it's understandable that some investors might want to stay away from Moderna. However, there's a bigger story to keep in mind. While there are certainly some reasons to steer clear of Moderna, there are also at least 330 million reasons to buy the stock right now.
Image source: Getty Images.
Source Fool.com
